Checkout
Cart: $0.00 - (0 items )

NIH researchers make progress toward Epstein-Barr virus (EBV) vaccine, with novel vaccine candidates that, in animals, elicited potent anti-EBV antibody responses that blocked infection of cell types involved in EBV-associated cancers. Worldwide, EBV-associated cancers results in 140,000 deaths.

NIH researchers make progress toward Epstein-Barr virus (EBV) vaccine, with novel vaccine candidates that, in animals, elicited potent anti-EBV antibody responses that blocked infection of cell types involved in EBV-associated cancers. Worldwide, EBV-associated cancers results in 140,000 deaths. submitted by /u/mvea
[link] [comments]

[Read More …]

Check out the Wellness topics

and 

Online Shopping Website

Back to top